vs
Bon Natural Life Ltd(BON)与Mind Medicine (MindMed) Inc.(DFTX)财务数据对比。点击上方公司名可切换其他公司
Bon Natural Life Ltd的季度营收约是Mind Medicine (MindMed) Inc.的11.2倍($10.2M vs $906.0K)。Bon Natural Life Ltd净利率更高(-0.4% vs -2634.0%,领先2633.6%)
该品牌(Au Bon Pain)是美国休闲快餐烘焙连锁咖啡馆,总部位于得克萨斯州理查森,截至2025年,在美国开设了34家门店,同时在泰国也设有多家分店,目前归百胜品牌加盟商管理公司AMPEX Brands所有。
Definium Therapeutics(前称MindMed)是一家总部位于纽约的生物技术企业,专注于致幻剂及更广泛的精神可塑性药物的临床与治疗应用开发,在中枢神经药物研发领域深耕相关创新疗法的落地潜力。
BON vs DFTX — 直观对比
营收规模更大
BON
是对方的11.2倍
$906.0K
净利率更高
BON
高出2633.6%
-2634.0%
损益表 — Q2 2025 vs Q4 2023
| 指标 | ||
|---|---|---|
| 营收 | $10.2M | $906.0K |
| 净利润 | $-41.8K | $-23.9M |
| 毛利率 | 29.1% | — |
| 营业利润率 | 0.8% | -2450.8% |
| 净利率 | -0.4% | -2634.0% |
| 营收同比 | — | -16.1% |
| 净利润同比 | — | -386.7% |
| 每股收益(稀释后) | — | $-0.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BON
DFTX
| Q1 25 | $10.2M | — | ||
| Q3 24 | $23.8M | — | ||
| Q1 24 | $14.1M | — | ||
| Q4 23 | — | $906.0K | ||
| Q3 23 | — | $1.2M | ||
| Q2 23 | — | $1.3M | ||
| Q1 23 | — | $1.3M | ||
| Q4 22 | — | $1.1M |
净利润
BON
DFTX
| Q1 25 | $-41.8K | — | ||
| Q3 24 | $398.2K | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-23.9M | ||
| Q3 23 | — | $-17.9M | ||
| Q2 23 | — | $-29.1M | ||
| Q1 23 | — | $-24.8M | ||
| Q4 22 | — | $-4.9M |
毛利率
BON
DFTX
| Q1 25 | 29.1% | — | ||
| Q3 24 | 29.8% | — | ||
| Q1 24 | 33.3% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
营业利润率
BON
DFTX
| Q1 25 | 0.8% | — | ||
| Q3 24 | 7.9% | — | ||
| Q1 24 | 21.1% | — | ||
| Q4 23 | — | -2450.8% | ||
| Q3 23 | — | -1858.6% | ||
| Q2 23 | — | -2226.1% | ||
| Q1 23 | — | -1624.8% | ||
| Q4 22 | — | -1287.0% |
净利率
BON
DFTX
| Q1 25 | -0.4% | — | ||
| Q3 24 | 1.7% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -2634.0% | ||
| Q3 23 | — | -1541.1% | ||
| Q2 23 | — | -2222.0% | ||
| Q1 23 | — | -1932.6% | ||
| Q4 22 | — | -454.0% |
每股收益(稀释后)
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | $4.14 | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-0.58 | ||
| Q3 23 | — | $-0.45 | ||
| Q2 23 | — | $-0.76 | ||
| Q1 23 | — | $-0.65 | ||
| Q4 22 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $99.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $44.3M | $78.1M |
| 总资产 | $61.8M | $124.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | $80.5K | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $99.7M | ||
| Q3 23 | — | $117.7M | ||
| Q2 23 | — | $116.9M | ||
| Q1 23 | — | $129.4M | ||
| Q4 22 | — | $142.1M |
总债务
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | $1.4M | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
股东权益
BON
DFTX
| Q1 25 | $44.3M | — | ||
| Q3 24 | $43.9M | — | ||
| Q1 24 | $36.0M | — | ||
| Q4 23 | — | $78.1M | ||
| Q3 23 | — | $96.0M | ||
| Q2 23 | — | $106.0M | ||
| Q1 23 | — | $130.3M | ||
| Q4 22 | — | $150.9M |
总资产
BON
DFTX
| Q1 25 | $61.8M | — | ||
| Q3 24 | $61.8M | — | ||
| Q1 24 | $46.6M | — | ||
| Q4 23 | — | $124.5M | ||
| Q3 23 | — | $141.6M | ||
| Q2 23 | — | $142.1M | ||
| Q1 23 | — | $155.5M | ||
| Q4 22 | — | $170.0M |
负债/权益比
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | 0.03× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.9M | $-20.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
BON
DFTX
| Q1 25 | $-1.9M | — | ||
| Q3 24 | $-7.7M | — | ||
| Q1 24 | $-2.2M | — | ||
| Q4 23 | — | $-20.6M | ||
| Q3 23 | — | $-16.6M | ||
| Q2 23 | — | $-13.8M | ||
| Q1 23 | — | $-13.3M | ||
| Q4 22 | — | $-12.8M |
自由现金流
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | $-7.7M | — | ||
| Q1 24 | $-2.2M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
自由现金流率
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | -32.4% | — | ||
| Q1 24 | -15.5% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
资本支出强度
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
现金转化率
BON
DFTX
| Q1 25 | — | — | ||
| Q3 24 | -19.40× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图